It has been reported that pirfenidone, which is an anti-fibrotic agent used for idiopathic pulmonary fibrosis, also exhibits anti-TNF-α and anti-TGF-β1 effect. This evidence concerns the gene TGFB1 and pulmonary fibrosis.